NeoProfen (ibuprofen lysine) Solution
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   January 2016 ADVERSE REACTIONS Post marketing Experience *added term Pulmonary hypertension ... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - January 1, 2016 Category: Drugs & Pharmacology Source Type: alerts